Basic Information
| LncRNA/CircRNA Name | circ_0060060 |
| Synonyms | circEIF6 |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | autophagy | Drug | Cisplatin | |
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR, western blot, luciferase reporter assay |
| Sample | PTC cell line,ATC cell line |
| Expression Pattern | differential expressed |
| Function Description | Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation. |
| Pubmed ID | 30540564 |
| Year | 2018 |
| Title | Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation. |
External Links
| Links for circ_0060060 | GenBank HGNC NONCODE |
| Links for thyroid cancer | OMIM COSMIC |